Issued Patents 2023
Showing 1–25 of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11851426 | Bicyclic amines as CDK2 inhibitors | Yingda Ye, Zhenwu Li, Ding-Quan Qian, Sarah Winterton, Liangxing Wu | 2023-12-26 |
| 11840546 | Imidazopyridazine compounds and uses thereof | Jun Pan, Yu Sheng Bai, Liangxing Wu | 2023-12-12 |
| 11840534 | Substituted tricyclic compounds as FGFR inhibitors | Liangxing Wu, Colin Zhang, Chunhong He, Liang Lu | 2023-12-12 |
| 11795166 | Pyrazolopyridine compounds and uses thereof | Oleg Vechorkin, Jun Pan, Kai Liu, Alexander Sokolsky, Anlai Wang +1 more | 2023-10-24 |
| 11787793 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Jingwei Li | 2023-10-17 |
| 11780840 | Tricyclic urea compounds as JAK2 V617F inhibitors | Yanran Ai, Onur Atasoylu, Yu Sheng Bai, Joseph Barbosa, David M. Burns +11 more | 2023-10-10 |
| 11767320 | Bicyclic dione compounds as inhibitors of KRAS | Taisheng Huang, Xiaozhao Wang | 2023-09-26 |
| 11767323 | Tricyclic pyridone compounds as JAK2 V617F inhibitors | Kai Liu, Onur Atasoylu, Yu Sheng Bai, Andrew W. Buesking, Leah C. Konkol +4 more | 2023-09-26 |
| 11753413 | Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors | Zhiyong Yu, Liangxing Wu | 2023-09-12 |
| 11739102 | Fused pyrimidine compounds as KRAS inhibitors | Gia Hoang, Xiaozhao Wang | 2023-08-29 |
| 11731958 | Carboxamide compounds and uses thereof | Oleg Vechorkin, Jun Pan, Alexander Sokolsky, Evan Styduhar | 2023-08-22 |
| 11718605 | Heterocyclic compounds as immunomodulators | Zhiyong Yu, Liangxing Wu | 2023-08-08 |
| 11713317 | Tricyclic heterocyclic compounds as sting activators | Liangxing Wu, Neil Lajkiewicz, Yingda Ye, Zhenwu Li | 2023-08-01 |
| 11691971 | Naphthyridinone compounds as JAK2 V617F inhibitors | Stacey Shepard, Lixin Shao, Liangxing Wu | 2023-07-04 |
| 11673894 | Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors | Xiaozhao Wang, Pei Gan, Taisheng Huang, Chao Qi, Ding-Quan Qian +5 more | 2023-06-13 |
| 11673883 | Heterocyclic compounds as immunomodulators | Liang Lu, Ding-Quan Qian, Liangxing Wu | 2023-06-13 |
| 11667635 | Bicyclic heterocycles as FGFR4 inhibitors | Liang Lu, Liangxing Wu, Ding-Quan Qian | 2023-06-06 |
| 11661422 | Tricyclic urea compounds as JAK2 V617F inhibitors | Kai Liu, Brent Douty, Daniel Levy, Liangxing Wu, Eddy W. Yue | 2023-05-30 |
| 11613536 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Fenglei Zhang, Song Mei | 2023-03-28 |
| 11607416 | Bicyclic heterocycles as FGFR inhibitors | Oleg Vechorkin, Minh Ngoc Nguyen, Chao Qi, Anlai Wang, Michael Witten +4 more | 2023-03-21 |
| 11608337 | Heterocyclic compounds as immunomodulators | Zhenwu Li, Liangxing Wu | 2023-03-21 |
| 11596692 | PD-L1/STING conjugates and methods of use | Liangxing Wu, Zhenwu Li | 2023-03-07 |
| 11591329 | Bicyclic heterocycles as FGFR inhibitors | Oleg Vechorkin, Chao Qi, Minh Ngoc Nguyen, Anlai Wang | 2023-02-28 |
| 11572366 | Heterocyclic compounds as immunomodulators | Jingwei Li, Liangxing Wu | 2023-02-07 |
| 11566026 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Bo Shen, Meizhong Xu | 2023-01-31 |